Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 5/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | RBP4 | P02753 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23064386 | 0.83 | TRPA1 (0.51) | TRPA1TRPV1 | |
| SCHEMBL23064385 | 0.83 | TRPA1 (0.51) | TRPA1TRPV1 | |
| SCHEMBL25844260 | 0.82 | RBP4 (0.48) | TRPA1TRPV1RBP4 | |
| SCHEMBL23064353 | 0.82 | RORC (0.42) | TRPV1HSD11B1 | |
| SCHEMBL23064356 | 0.82 | RORC (0.42) | TRPV1HSD11B1 | |
| SCHEMBL30778002 | 0.82 | RORC (0.42) | TRPV1HSD11B1 | |
| SCHEMBL31050098 | 0.75 | RORC (0.48) | TRPV1HSD11B1 | |
| SCHEMBL30633886 | 0.71 | TRPA1 (0.52) | TRPA1TRPV1RBP4 | |
| SCHEMBL23064252 | 0.71 | TRPA1 (0.52) | TRPA1TRPV1RBP4 | |
| SCHEMBL23064280 | 0.70 | MAPT (0.37) | TRPV1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023163203-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING RENAL DISEASE | 国立大学法人大阪大学 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023132208-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HEART FAILURE | 国立大学法人大阪大学 | 2023-07-13 | — | — | WO | disclosed |